BFI and BIRAC ink a Letter of Intent to advance biomedical innovation

Blockchain for Impact (BFI), a philanthropic organisation, has signed a Letter of Intent to collaborate with the Biotechnology Industry Research Assistance Council (BIRAC), Department of Biotechnology, Government of India, marking a significant...

Lupin Forays into non-exclusive patent licensing agreement with Takeda

Leading pharmaceutical company Lupin Limited has revealed a non-exclusive patent license agreement with Takeda Pharmaceutical Company Limited to sell vonoprazan tablets in India. Lupin will be launching their new drug, Lupivon, in two different...

Zydus Lifesciences to acquire Sterling Biotech's API biz for Rs 84 crore

Zydus Lifesciences Ltd announced that it will acquire Sterling Biotech's 'Target Business', which is principally engaged in the manufacturing process of fermentation-based active pharmaceutical ingredients products, as well as a production facility..

ORDI & St John's Medical College Team Up to Support Kidney Disease Patients

The Organisation for Rare illnesses India (ORDI) and St John's Medical College and Hospital have signed a Memorandum of Understanding (MoU) to help children with rare kidney illnesses and their families. These include about 150 rare illnesses...

Max Healthcare acquires Jaypee Healthcare For 1,660 crore

Max Healthcare has announced a strategic partnership with Lakshdeep Group to obtain a majority share in Jaypee Healthcare, which is currently in Corporate Insolvency Resolution Process (CIRP). The purchase is valued at Rs 1,660 crore in terms of...

Stealth to develop mitochondrial therapeutic for Friedreich's ataxia

Stealth BioTherapeutics Inc., a biotech company in clinical stage, and Friedreich’s Ataxia Research Alliance (FARA) have announced that Stealth has received the Kyle Bryant Translational Research Award from FARA to study SBT-589 in Friedreich’s...

Eli Lilly Funds $1.8 bln in Ireland sites to boost obesity drug production

Eli Lilly announced that it will invest $1.8 billion in two manufacturing facilities in Ireland to increase production of its highly popular obesity medication and a recently approved treatment for Alzheimer's disease. The funding is a...

Quantum Partners with Ingenu CRO for Study on MS Disease Progression

Quantum BioPharma Ltd, a company focused on developing a range of new assets and biotechnology solutions, has revealed that its subsidiary, HUGE Biopharma Australia Pty Ltd, has partnered with Ingenu CRO Pty Ltd to carry out a clinical study on...

Cabinet Nods Health Coverage For Senior Citizens Aged 70 years & above

The Prime Minister Narendra Modi-led Union Cabinet has given the green light for health coverage for all elderly citizens aged 70 and above, regardless of income, as part of the main scheme Ayushman Bharat Pradhan Mantri Jan Arogya Yojana...

Strides Bags shareholder's Approval for OneSource Specialty CDMO unit

Strides Pharma Science announced that it has gained approval from both equity shareholders and secured creditors to establish OneSource, a specialized pharmaceutical Contract Development and Manufacturing Organization (CDMO). In a statement...

© 2024 India Pharma Outlook. All Rights Reserved.